AP450A - Use of dideoxy nucleoside analogues in the treatment of viral infections. - Google Patents

Use of dideoxy nucleoside analogues in the treatment of viral infections. Download PDF

Info

Publication number
AP450A
AP450A APAP/P/1993/000603A AP9300603A AP450A AP 450 A AP450 A AP 450A AP 9300603 A AP9300603 A AP 9300603A AP 450 A AP450 A AP 450A
Authority
AP
ARIPO
Prior art keywords
enantiomer
compound
pharmaceutically acceptable
use according
treatment
Prior art date
Application number
APAP/P/1993/000603A
Other languages
English (en)
Other versions
AP9300603A0 (en
Inventor
Tarek Mansour
Allan H L Tse
Original Assignee
Iaf Biochem Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iaf Biochem Int filed Critical Iaf Biochem Int
Publication of AP9300603A0 publication Critical patent/AP9300603A0/xx
Application granted granted Critical
Publication of AP450A publication Critical patent/AP450A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
APAP/P/1993/000603A 1992-12-24 1993-12-23 Use of dideoxy nucleoside analogues in the treatment of viral infections. AP450A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929226927A GB9226927D0 (en) 1992-12-24 1992-12-24 Dideoxy nucleoside analogues

Publications (2)

Publication Number Publication Date
AP9300603A0 AP9300603A0 (en) 1994-01-31
AP450A true AP450A (en) 1996-01-19

Family

ID=10727197

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1993/000603A AP450A (en) 1992-12-24 1993-12-23 Use of dideoxy nucleoside analogues in the treatment of viral infections.

Country Status (21)

Country Link
US (1) US6156737A (es)
EP (2) EP0675724B1 (es)
JP (2) JP2818299B2 (es)
KR (1) KR100331714B1 (es)
AP (1) AP450A (es)
AT (1) ATE157877T1 (es)
AU (1) AU681370B2 (es)
CA (1) CA2143204C (es)
DE (1) DE69313872T2 (es)
DK (1) DK0675724T3 (es)
ES (1) ES2108969T3 (es)
GB (1) GB9226927D0 (es)
GR (1) GR3024699T3 (es)
HK (1) HK1002426A1 (es)
IL (1) IL108063A (es)
MY (1) MY127808A (es)
NZ (1) NZ259487A (es)
RU (1) RU2160108C2 (es)
SG (1) SG48956A1 (es)
WO (1) WO1994014456A1 (es)
ZA (1) ZA939677B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728575A (en) * 1990-02-01 1998-03-17 Emory University Method of resolution of 1,3-oxathiolane nucleoside enantiomers
US5276151A (en) * 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
US5444063A (en) * 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
US5817667A (en) * 1991-04-17 1998-10-06 University Of Georgia Research Foudation Compounds and methods for the treatment of cancer
TW374087B (en) * 1993-05-25 1999-11-11 Univ Yale L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents
US5627160A (en) * 1993-05-25 1997-05-06 Yale University L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents
JPH09504785A (ja) 1993-09-10 1997-05-13 エモリー、ユニバーシティー 抗ｂ型肝炎ウイルス活性を有するヌクレオシド
US20020120130A1 (en) 1993-09-10 2002-08-29 Gilles Gosselin 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents
US5587362A (en) * 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
IL115156A (en) 1994-09-06 2000-07-16 Univ Georgia Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines
US5703058A (en) * 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
US6391859B1 (en) * 1995-01-27 2002-05-21 Emory University [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
US5808040A (en) * 1995-01-30 1998-09-15 Yale University L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides
US5869461A (en) * 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
AU722214B2 (en) 1995-06-07 2000-07-27 Centre National De La Recherche Scientifique (Cnrs) Nucleosides with anti-hepatitis B virus activity
US6100301A (en) * 1996-02-28 2000-08-08 Pfizer Inc Combination therapy to treat osteoporosis-polyphosphonates and estrogen agonists
US5753789A (en) * 1996-07-26 1998-05-19 Yale University Oligonucleotides containing L-nucleosides
ZA984796B (en) * 1997-06-10 1998-12-29 Chong Kun Dang Corp Novel optically active nucleoside derivative its manufacturing method and anti-HBV composition containing the derivative thereof
US7635690B2 (en) 1999-01-22 2009-12-22 Emory University HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
US7115584B2 (en) * 1999-01-22 2006-10-03 Emory University HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0285884A2 (en) * 1987-03-20 1988-10-12 Bristol-Myers Squibb Company Process to produce 2', 3'-Dideoxynucleosides
EP0352248A1 (en) * 1988-07-20 1990-01-24 Medivir Aktiebolag Nucleoside derivatives

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
EP0206497B1 (en) * 1985-05-15 1994-07-20 The Wellcome Foundation Limited Therapeutic nucleosides and their preparation
US4788181A (en) * 1986-09-29 1988-11-29 The United States Of America As Represented By The Department Of Health And Human Services 5-substituted-2',3'-dideoxycytidine compounds with anti-HTLV-III activity
US5215970A (en) * 1987-04-16 1993-06-01 Medivir Ab Nucleosides and nucleotide analogues, pharmaceutical composition and processes for the preparation of the compounds
CA1327000C (en) * 1987-08-07 1994-02-15 David L.J. Tyrrell Antiviral therapy for hepatitis b
US5039667A (en) * 1987-08-07 1991-08-13 The Governors Of The University Of Alberta Antiviral therapy for hepatitis B with 2',3'-dideoxypurine nucleosides
AU5659990A (en) * 1989-05-15 1990-12-18 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Method of treatment of hepatitis
SE464168B (sv) * 1989-07-19 1991-03-18 Bo Fredrik Oeberg Antiviral komposition bestaaende av en 3'-fluoro-2',3'-dideoxynukleosidfoerening och en 2',3'-dideoxynukleosidfoerening (exempelvis azt)
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
US5179104A (en) * 1990-12-05 1993-01-12 University Of Georgia Research Foundation, Inc. Process for the preparation of enantiomerically pure β-D-(-)-dioxolane-nucleosides
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
NZ250842A (en) * 1991-02-22 1996-03-26 Univ Emory Resolution of a racemic mixture of nucleoside enantiomers such as 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane (ftc)
AU662130B2 (en) * 1991-03-06 1995-08-24 Emory University Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis B
WO1992018517A1 (en) * 1991-04-17 1992-10-29 Yale University Method of treating or preventing hepatitis b virus
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923641B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9116601D0 (en) * 1991-08-01 1991-09-18 Iaf Biochem Int 1,3-oxathiolane nucleoside analogues
TW374087B (en) * 1993-05-25 1999-11-11 Univ Yale L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents
JPH09222548A (ja) * 1996-02-19 1997-08-26 Asahi Optical Co Ltd レンズ駆動機構

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0285884A2 (en) * 1987-03-20 1988-10-12 Bristol-Myers Squibb Company Process to produce 2', 3'-Dideoxynucleosides
EP0352248A1 (en) * 1988-07-20 1990-01-24 Medivir Aktiebolag Nucleoside derivatives

Also Published As

Publication number Publication date
WO1994014456A1 (en) 1994-07-07
CA2143204C (en) 1997-06-03
RU2160108C2 (ru) 2000-12-10
JP2818299B2 (ja) 1998-10-30
AP9300603A0 (en) 1994-01-31
ZA939677B (en) 1994-08-26
DK0675724T3 (da) 1998-03-09
DE69313872T2 (de) 1998-01-08
JPH10139668A (ja) 1998-05-26
ES2108969T3 (es) 1998-01-01
GB9226927D0 (en) 1993-02-17
JPH07509730A (ja) 1995-10-26
IL108063A0 (en) 1994-04-12
KR100331714B1 (ko) 2002-11-01
HK1002426A1 (en) 1998-08-21
MY127808A (en) 2006-12-29
DE69313872D1 (de) 1997-10-16
US6156737A (en) 2000-12-05
EP0675724B1 (en) 1997-09-10
IL108063A (en) 1999-10-28
EP0765665A1 (en) 1997-04-02
ATE157877T1 (de) 1997-09-15
AU5830194A (en) 1994-07-19
EP0675724A1 (en) 1995-10-11
NZ259487A (en) 1997-06-24
AU681370B2 (en) 1997-08-28
CA2143204A1 (en) 1994-07-07
SG48956A1 (en) 1998-05-18
GR3024699T3 (en) 1997-12-31

Similar Documents

Publication Publication Date Title
AP450A (en) Use of dideoxy nucleoside analogues in the treatment of viral infections.
EP0565549B1 (en) Use of 1,3-oxathiolane nucleoside analogues in the manufacture of a medicament for treatment of hepatitis b
US6232300B1 (en) Treatment of HIV by administration of β-D-2′, 3′-didehydro-2′,3′-dideoxy-5-fluorocytidine (D4FC)
US6417191B1 (en) Synergistic combinations of zidovudine, 1592U89 and 3TC
EP0526253A1 (en) 1,3-Oxathiolane nucleoside analogues
US6391859B1 (en) [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
EP0346132B1 (en) Pharmaceutical products
US6358963B1 (en) Antiviral nucleoside analogues
EP0639971B1 (en) Therapeutic combinations
NZ314731A (en) Use of dideoxycytosine derivatives in medicaments for treating hepatitis b viral infections
JPH07508998A (ja) 抗ウイルス剤の組み合わせ
ZA200305423B (en) DAPD combination therapy with IMDPH inhibitors such as ribavirin or mycophenolic acid.